Literature DB >> 4177208

Beta-adrenergic blockade in thyrotoxic myopathy.

N Pimstone, N Marine, B Pimstone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4177208     DOI： 10.1016/s0140-6736(68)91697-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Propranolol and serum calcium in thyrotoxicosis.

Authors:  Y K Seedat; A I Vinik; E G Stewart-Wynne
Journal:  Br Med J       Date:  1970-08-29

2.  The use of propranolol in the surgical treatment of thyrotoxic patients.

Authors:  T C Lee; R J Coffey; J Mackin; M Cobb; J Routon; J J Canary
Journal:  Ann Surg       Date:  1973-06       Impact factor: 12.969

3.  Experience with the use of propranolol in the surgical management of thyrotoxicosis.

Authors:  J R Starling; C G Thomas
Journal:  World J Surg       Date:  1977-03       Impact factor: 3.352

Review 4.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

5.  Propranolol and thyroidectomy in the treatment of thyrotoxicosis.

Authors:  T C Lee; R J Coffey; B M Currier; X P Ma; J J Canary
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

6.  Comparison of propranolol and metoprolol in the management of hyperthyroidism.

Authors:  L E Murchison; J How; P D Bewsher
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

Review 7.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.